Insecticid.India

how big is Insecticid.India?

As of Jun 06, Insecticides India Ltd has a market capitalization of 2,491.84 Cr, classifying it as a Small Cap company, with recent net sales of 2000.40 Cr and net profit of 141.76 Cr.

Market Cap: As of Jun 06, Insecticides India Ltd has a market capitalization of 2,491.84 Cr, which classifies it as a Small Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, the sum of Net Sales is 2000.40 Cr, and the sum of Net Profit is 141.76 Cr. This data is Consolidated.<BR><BR>Balance Sheet Snapshot: This is Consolidated data for the latest annual period ending in Mar'24. Shareholder's Funds are reported at 1,013.53 Cr, and Total Assets amount to 1,713.50 Cr.

When is the next results date for Insecticid.India?

No Upcoming Board Meetings

Who are in the management team of Insecticid.India?

As of March 2022, the management team of Insecticid.India includes Hari Chand Aggarwal (Chairman), Rajesh Aggarwal (Managing Director), and several independent directors, along with whole-time directors and a compliance officer.

As of March 2022, the management team of Insecticid.India includes the following members:<BR><BR>1. Hari Chand Aggarwal - Chairman & Wholetime Director<BR>2. Rajesh Aggarwal - Managing Director<BR>3. NAVIN SHAH - Independent Director<BR>4. Virjesh Kumar Gupta - Independent Director<BR>5. Nikunj Aggarwal - Whole-time Director<BR>6. Jayaraman Swaminathan - Independent Director<BR>7. Sandeep Kumar - Company Secretary & Compliance Officer<BR>8. Parveen Gupta - Independent Director<BR>9. Anil Kumar Bhatia - Independent Director<BR>10. Anil Kurnar Goyal - Whole-time Director<BR><BR>The team comprises a mix of executive and independent directors, alongside a compliance officer.

What does Insecticid.India do?

Insecticides India Ltd is a small-cap company in the Pesticides & Agrochemicals industry, producing insecticides and agrochemical products. As of March 2025, it reported net sales of ₹359 Cr and a net profit of ₹14 Cr, with a market cap of ₹2,488 Cr.

Overview:<BR>Insecticides India Ltd is a small-cap company operating in the Pesticides & Agrochemicals industry, primarily engaged in the production of insecticides and agrochemical products.<BR><BR>History:<BR>Incorporated in 1996 as 'Insecticides (India) Private Limited', the company transitioned to a Public Limited Company and commenced commercial production in March 2002. The latest reported quarter for net sales and profit is March 2025.<BR><BR>Financial Snapshot:<BR>- Net Sales: 359 Cr (Quarterly Results - Mar 2025)<BR>- Net Profit: 14 Cr (Quarterly Results - Mar 2025)<BR>- Market Cap: Rs 2,488 Cr (Small Cap)<BR><BR>Key Metrics:<BR>- P/E: 17.00<BR>- Industry P/E: 38<BR>- Dividend Yield: 0.24%<BR>- Debt-Equity: 0.04<BR>- Return on Equity: 13.07%<BR>- Price to Book: 2.29<BR><BR>Contact Details:<BR>Address: 401-402 Lusa Tower, Azadpur Commercial Complex Delhi Delhi : 110033<BR>Tel: 91-11-27671990-04<BR>Email: investor@insecticidesindia.com<BR>Website: http://www.insecticidesindia.com

What is the bonus history of the Insecticid.India?

Insecticides India Ltd has a history of issuing bonus shares, with the most recent being a 1:2 bonus announced on September 30, 2022, and a previous 1:2 bonus issued on April 17, 2015. This reflects the company's commitment to rewarding its shareholders.

Insecticides India Ltd has a history of bonus issues. The most recent bonus was a 1:2 issue, which was announced with an ex-date of September 30, 2022, and the record date was October 3, 2022. Prior to that, the company also issued a bonus in a 1:2 ratio on April 17, 2015, with an ex-date of April 16, 2015. This indicates that the company has consistently rewarded its shareholders with bonus shares in the past.

Who are the peers of the Insecticid.India?

Peers of Insecticid.India include P I Industries, UPL, Bayer CropSci., and others. Insecticid.India has average management risk, below average growth, and the highest 1-year return at 65.72%.

Peers: The peers of Insecticid.India are P I Industries, UPL, Bayer CropSci., Sumitomo Chemi., Dhanuka Agritech, India Pesticides, Meghmani Organi., Punjab Chemicals, Astec Lifescienc, and Heranba Inds.<BR><BR>Quality Snapshot: Excellent management risk is observed at Bayer CropSci., Dhanuka Agritech, and P I Industries, while Good management risk is found at Sumitomo Chemi. Average management risk is present at Insecticid.India, UPL, India Pesticides, Punjab Chemicals, and Heranba Inds. Below Average management risk is noted at Meghmani Organi. and Astec Lifescienc. For growth, Excellent growth is seen only at P I Industries, while Below Average growth is found at Bayer CropSci., Sumitomo Chemi., Dhanuka Agritech, Insecticid.India, UPL, India Pesticides, Punjab Chemicals, and Heranba Inds, with Meghmani Organi. showing Below Average growth as well. Excellent capital structure is noted at P I Industries, Bayer CropSci., Sumitomo Chemi., Dhanuka Agritech, Insecticid.India, India Pesticides, and Punjab Chemicals, while Average capital structure is observed at Meghmani Organi. and Astec Lifescienc, and Below Average at UPL and Heranba Inds.<BR><BR>Return Snapshot: Insecticid.India has the highest 1-year return at 65.72%, while Astec Lifescienc has the lowest at -35.47%. Insecticid.India's return significantly outperforms Astec Lifescienc. Additionally, UPL, Meghmani Organi., Astec Lifescienc, and Heranba Inds have negative six-month returns.

Who are the top shareholders of the Insecticid.India?

The top shareholders of Insecticid.India include Rajesh Kumar Aggarwal with 16.63%, HDFC Small Cap Fund at 9.07%, and individual investors holding 10.43%. Foreign Institutional Investors collectively own 4.49%, with no pledged promoter holdings reported.

The top shareholders of Insecticid.India include the promoters, with Rajesh Kumar Aggarwal holding the highest individual stake at 16.63%. Additionally, mutual funds have a significant presence, with HDFC Small Cap Fund being the highest public shareholder at 9.07%. Foreign Institutional Investors (FIIs) collectively hold 4.49% through 45 different entities. Individual investors also have a notable share, accounting for 10.43% of the holdings. There are no pledged promoter holdings reported.

How has been the historical performance of Insecticid.India?

Insecticid.India has shown steady growth in net sales and profitability, with net sales increasing from 1,193.51 Cr in Mar'19 to 1,999.95 Cr in Mar'25, and profit after tax rising from 62.98 Cr to 141.45 Cr in the same period, despite rising operational costs. Total assets also grew to 1,898.15 Cr in Mar'25, indicating a positive overall financial trajectory.

Answer:<BR>The historical performance of Insecticid.India shows a steady growth in net sales and profitability over the years, with significant fluctuations in certain metrics.<BR><BR>Breakdown:<BR>Insecticid.India's net sales have increased from 1,193.51 Cr in Mar'19 to 1,999.95 Cr in Mar'25, reflecting a consistent upward trend. Total operating income followed a similar trajectory, reaching 1,999.95 Cr in Mar'25 from 1,801.33 Cr in Mar'23. However, total expenditure saw a rise to 1,778.74 Cr in Mar'25 from 1,679.44 Cr in Mar'23, indicating increased operational costs. The operating profit (PBDIT) has shown improvement, rising to 228.21 Cr in Mar'25 from 123.15 Cr in Mar'23, while profit before tax also increased to 192.20 Cr in Mar'25 from 83.60 Cr in Mar'23. Consequently, profit after tax reached 141.45 Cr in Mar'25, up from 62.98 Cr in Mar'23. The company's total assets grew to 1,898.15 Cr in Mar'25 from 1,696.31 Cr in Mar'23, while total liabilities increased to 1,898.15 Cr in Mar'25 from 1,719.22 Cr in Mar'24. Cash flow from operating activities improved significantly, resulting in a net cash inflow of 42.00 Cr in Mar'24, compared to a net outflow of 17.00 Cr in Mar'23. Overall, Insecticid.India has demonstrated a positive growth trajectory in sales and profits, despite some fluctuations in expenses and liabilities.

Is Insecticid.India overvalued or undervalued?

As of November 13, 2025, Insecticid.India's valuation has shifted from very attractive to attractive, indicating it is undervalued with a PE ratio of 13.04, an EV to EBITDA of 9.20, and a PEG ratio of 0.85, especially when compared to peers like UPL and P I Industries, despite a recent 1-year return of -12.71% against the Sensex's 8.74%.

As of 13 November 2025, the valuation grade for Insecticid.India has moved from very attractive to attractive. Based on the analysis, the company appears to be undervalued. The key ratios indicate a PE ratio of 13.04, an EV to EBITDA of 9.20, and a PEG ratio of 0.85, all of which suggest a favorable valuation compared to its peers.<BR><BR>Insecticid.India's valuation can be compared to UPL, which has a PE ratio of 26.8, and P I Industries, which is considered very expensive with a PE of 35.84. These comparisons highlight that Insecticid.India is trading at a significantly lower valuation relative to its peers in the pesticides and agrochemicals industry. Despite recent underperformance against the Sensex, with a 1-year return of -12.71% compared to the Sensex's 8.74%, the company's fundamentals suggest it is positioned for potential growth.

Is Insecticid.India technically bullish or bearish?

As of December 2, 2025, the market trend has shifted to a bearish stance with moderate strength, indicated by bearish MACD, Bollinger Bands, moving averages, and KST on various time frames, alongside a lack of trend signals in Dow Theory and OBV.

As of 2 December 2025, the technical trend has changed from mildly bearish to bearish. The current stance is bearish with moderate strength. Key indicators driving this include a bearish MACD on the weekly chart, bearish Bollinger Bands on both weekly and monthly time frames, and bearish moving averages on the daily chart. The KST is also bearish on the weekly chart, contributing to the overall bearish sentiment. The lack of trend signals in the Dow Theory and OBV further supports the bearish outlook.

Are Insecticides India Ltd latest results good or bad?

Insecticides India Ltd's latest Q3 FY26 results are concerning, with a net profit decline of 82.25% quarter-over-quarter and 39.61% year-over-year, despite a 7.61% year-over-year increase in net sales. The significant drop in profitability and operating margins indicates serious operational challenges for the company.

Insecticides India Ltd's latest results for Q3 FY26 are concerning. The company reported a net profit of ₹10.49 crore, which reflects a significant decline of 82.25% quarter-over-quarter and 39.61% year-over-year. This sharp drop in profitability raises red flags about the company's operational efficiency and pricing power during a traditionally weaker demand period.<BR><BR>While net sales for the quarter were ₹384.92 crore, showing a year-over-year increase of 7.61%, this was accompanied by a steep sequential decline of 39.64%. The operating margin also fell to 7.12%, the lowest in eight quarters, indicating severe margin compression. Additionally, the profit after tax (PAT) margin decreased dramatically to 2.73%, down 655 basis points from the previous quarter.<BR><BR>Overall, the results suggest that Insecticides India is facing significant operational challenges, and the deterioration in key financial metrics has prompted concerns about the company's near-term earnings trajectory. Investors may need to reassess their outlook on the company given these developments.

Should I buy, sell or hold Insecticides India Ltd?

Has Insecticides India Ltd declared dividend?

Yes, Insecticides India Ltd has declared a 20% dividend, amounting to ₹2 per share, with an ex-date of February 6, 2026. While recent total returns have been negative, longer-term performance shows significant growth, particularly a 93.57% total return over the past five years.

Insecticides India Ltd has declared a dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 20%<BR>- Amount per share: 2<BR>- Ex-date: 06 Feb 26<BR><BR>Dividend Yield: 0%<BR><BR>Total Returns by Period:<BR>In the 3-month period, the price return was -16.61%, the dividend return was 0.28%, resulting in a total return of -16.33%.<BR><BR>In the 6-month period, the price return was -43.79%, the dividend return was 0.19%, leading to a total return of -43.6%.<BR><BR>Over the 1-year period, the price return was -4.29%, the dividend return was 0.32%, which resulted in a total return of -3.97%.<BR><BR>In the 2-year period, the price return was -6.92%, the dividend return was 0.71%, culminating in a total return of -6.21%.<BR><BR>During the 3-year period, the price return was 4.63%, the dividend return was 1.75%, resulting in a total return of 6.38%.<BR><BR>In the 4-year period, the price return was 28.32%, the dividend return was 3.10%, leading to a total return of 31.42%.<BR><BR>For the 5-year period, the price return was 89.25%, the dividend return was 4.32%, resulting in a total return of 93.57%.<BR><BR>Overall, while Insecticides India Ltd has declared a dividend, the total returns over the shorter periods have been negative, indicating a challenging performance in the recent past. However, the longer-term returns show significant growth, particularly over the 5-year period.

Which are the latest news on Insecticid.India?

Why is Insecticides India Ltd falling/rising?

As of 03-Feb, Insecticides India Ltd's stock price is at 602.75, down 0.68%, and has significantly underperformed the Sensex, declining 14.99% over the past month. The stock's bearish trend is compounded by negative financial results and waning investor interest, indicating a lack of confidence in the company's future prospects.

As of 03-Feb, Insecticides India Ltd's stock price is falling, currently at 602.75, reflecting a decrease of 4.1 points or 0.68%. The stock has underperformed significantly compared to the benchmark Sensex, which has gained 2.30% over the past week while Insecticides India Ltd has dropped by 5.75%. Over the past month, the stock has experienced a decline of 14.99%, contrasting with a slight decrease of 2.36% in the Sensex.<BR><BR>Today, the stock has continued its downward trend, marking its second consecutive day of losses with a total decline of 1.08% in this period. The stock's performance today is notably weak, underperforming its sector by 3.72%. Additionally, it has been trading below all key moving averages, indicating a bearish trend. The stock reached an intraday high of Rs 627.4, but this was not sustained, further contributing to the decline.<BR><BR>Investor participation appears to be waning, as evidenced by a significant drop in delivery volume, which fell by 52.58% compared to the 5-day average. This lack of interest from investors, combined with the stock's consistent underperformance against benchmarks over the last three years, suggests a lack of confidence in the company's future prospects.<BR><BR>Moreover, the company has reported negative financial results, including a 39.6% drop in profit after tax for the recent quarter, which further exacerbates concerns about its long-term growth potential. Despite a low debt to EBITDA ratio and some positive valuation metrics, the overall sentiment remains negative due to the company's poor performance relative to its peers and the broader market.